COVID-19: -

Our Commitment to Client Service & Investor Communications

Sunday Summary

19 Sep 2021 / News

The Sunday Summary provides an overview of Hardman & Co research published over the past seven days, as well as an update on other Hardman happenings.




Neodecortech (NDT)

Business booming

13 September 2021 | Paper & Packaging

Oakley Capital Investments (OCI)

1H’21: 35% EBITDA growth drives 26% NAV return

13 September 2021 | Inv. banking & brokerage services

ICG Enterprise Trust (ICGT)

ICGT in personal pensions: do as the professionals do

16 September 2021 | Closed End Investment Funds

Diurnal (DNL)

All set for three pivotal trials

16 September 2021 | Pharmaceuticals & Biotechnology



Q&A with Mark Thomas | MORhomes. Analyst Mark Thomas discussed his recent note on MORhomes, ‘Sustainable bond framework and earnings’, with Larissa Adams.

DirectorsTalk | Appreciate Group Plc. Mark joins DirectorsTalk to tell us more about the business, how digitalisation is an important growing trend, the PayPoint deal and what we learnt from the latest results.

Hardman Talks | Investor access with Robert Mundy of Research Tree. Uniquely positioned between all financial market players, Robert and Larissa talk about the widely discussed role of the retail investor and the impact COVID-19 has had on investor access.

Hardman Talks | Yew Grove REIT (YEW) results webinar. Yew Grove reviewed its latest interim results, which showed a raised dividend and a 2.4% like-for-like upward revaluation of its investment properties (a rise over a six-month period).



Life Sciences Investor Forum | 23 September 2021. Register now for your spot at our forthcoming Life Sciences Forum, featuring presentations from Diurnal, Incanthera and Shield Therapeutics, as well as on-the-spot analysis from our Head of Life Sciences, Dr Martin Hall.